Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 6/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 6/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8340001 | 0.94 | SMN1; SMN2 (0.36) | TAS1R3TAS1R1SMN1; SMN2HIF1AGLA | |
| SCHEMBL8337752 | 0.93 | SMN1; SMN2 (0.35) | SMN1; SMN2HIF1A | |
| SCHEMBL8336318 | 0.92 | SMPD1 (0.35) | SMN1; SMN2 | |
| SCHEMBL8389248 | 0.92 | TAS1R3 (0.32) | TAS1R3TAS1R1SMN1; SMN2HIF1ASLC6A4 | |
| SCHEMBL8339968 | 0.92 | HIF1A (0.35) | SMN1; SMN2HIF1A | |
| SCHEMBL8334657 | 0.90 | SMN1; SMN2 (0.34) | TAS1R3TAS1R1SMN1; SMN2HIF1A | |
| SCHEMBL8338131 | 0.88 | HIF1A (0.35) | SMN1; SMN2HIF1A | |
| SCHEMBL8337233 | 0.87 | SMN1; SMN2 (0.32) | SMN1; SMN2HIF1A | |
| SCHEMBL8339172 | 0.87 | SMN1; SMN2 (0.37) | TAS1R3TAS1R1SMN1; SMN2HIF1AGLA | |
| SCHEMBL8338614 | 0.87 | SMN1; SMN2 (0.35) | TAS1R3TAS1R1SMN1; SMN2HIF1AGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5977177-A | Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-11-02 | — | — | US | disclosed |
| US-5880155-A | TREATMENT OF CARDIOVASCULAR DISORDERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-03-09 | — | — | US | disclosed |